We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Gene Analysis Identifies People at Risk for Diabetes

By Biotechdaily staff writers
Posted on 05 Aug 2003
Researchers studying the genetic basis for diabetes have identified a group of 187 genes that are expressed differently in patients suffering from type 2 diabetes, and showed that 55 of these genes are expressed in asymptomatic individuals with a family history of the disease.

Investigators at Joslin Diabetes Center (Boston, MA, USA) used DNA microarray techniques to measure the expression of over 7,000 genes in muscle tissue from normal, diabetic, or pre-diabetic (having a family history of diabetes) Mexican-Americans, an ethnic group with a very high risk for diabetes. More...
They found that 187 genes were expressed differently between normals and diabetics, and that 166 genes were expressed differently between normals and pre-diabetics. A group of 55 genes were expressed differently in both groups.


Two of the 55 genes, PCG1-alpha and PCG1-beta, showed reduced expression that lead to the reduced activity of a larger group of genes involved in the metabolism of fats and carbohydrates. Many of the genes in the larger group encode for proteins in the mitochondria and are regulated by the NRF-1 gene. These findings were published in the July 8, 2003, issue of the Proceedings of the National Academy of Sciences.

"Knowing which genes are turned on or off in people before they develop diabetes is a key piece of information needed to solve the puzzle of diabetes, and to identify new ways to treat and prevent this devastating disease,” explained first author Dr. Mary-Elizabeth Patti, director of the genomics laboratory at Joslin Diabetes Center. "If we can identify people at high risk for diabetes and learn to prevent these changes from taking place, we may be able to find better methods for both treatment and prevention of diabetes.”



Related Links:
Joslin Diabetes Center

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: POC fingerstick blood testing enables faster hepatitis B DNA testing outside centralized laboratories (Photo courtesy of Conor Ashleigh)

POC Testing for Hepatitis B DNA as Effective as Traditional Laboratory Testing

Hepatitis B is a viral infection that attacks the liver and can lead to cirrhosis, liver failure, and liver cancer over time. Despite being preventable through vaccination and treatable in its chronic... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.